VGI Health Technology Limited (NSX:VTL) Hong Kong Patent Granted - ABN Newswire (@ABN_Newswire)

VGI Health Technology Limited (NSX:VTL) is pleased to announce that the Hong Kong Patent Office has granted a patent for the Transmucosal Delivery of Tocotrienols to its wholly-owned subsidiary, Invictus Biotechnology Pty Ltd.

Related Keywords

Australia ,Japan ,New Zealand ,Hong Kong ,Sydney ,New South Wales ,Singapore ,China ,South Africa ,Canada ,Australian ,Chinese , ,Hong Kong Patent Office ,European Union ,Health Technology Limited ,Health Technology ,Invictus Biotechnology Pty Ltd ,Hong Kong Patent ,Technology Limited ,Transmucosal Delivery ,Invictus Biotechnology Pty ,Delayed Onset Muscle Soreness ,Glenn Tong ,Chief Executive Officer ,Managing Director ,Non Alcoholic Fatty Liver Disease ,Non Alcoholic Steatohepatitis ,Biotech ,Clinical Trials ,Drugs Otc ,Vgi Health Technology Limited ,Nsx Vtl ,